A, P., S, G., A, A., L, C., RB, C., D, L., . . . CL, D. (2026). Functional in vitro assessment of the HER2 Ile655Val variant on trastuzumab-induced cardiotoxicity in human cardiomyocytes. European journal of pharmacology, 1012, 178484. https://doi.org/10.1016/j.ejphar.2025.178484
Chicago Style (17th ed.) CitationA, Pozo-Agundo, et al. "Functional in Vitro Assessment of the HER2 Ile655Val Variant on Trastuzumab-induced Cardiotoxicity in Human Cardiomyocytes." European Journal of Pharmacology 1012 (2026): 178484. https://doi.org/10.1016/j.ejphar.2025.178484.
MLA (9th ed.) CitationA, Pozo-Agundo, et al. "Functional in Vitro Assessment of the HER2 Ile655Val Variant on Trastuzumab-induced Cardiotoxicity in Human Cardiomyocytes." European Journal of Pharmacology, vol. 1012, 2026, p. 178484, https://doi.org/10.1016/j.ejphar.2025.178484.